相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
Amy S. Darefsky et al.
CANCER (2012)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Matthew Koshy et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis
Jan Kuhnhenn et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
Walter Taal et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial
Christoph Oehler et al.
ONCOLOGY (2012)
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
R. Stupp et al.
ANNALS OF ONCOLOGY (2011)
Carboplatin Chemotherapy in Patients with Recurrent High-grade Glioma
L. J. Murray et al.
CLINICAL ONCOLOGY (2011)
It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
Ufuk Abacioglu et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
Raffaele Addeo et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Salvage therapy with single agent bendamustine for recurrent glioblastoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan
Jeffrey N. Bruce et al.
NEUROSURGERY (2011)
Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma
N. Schaefer et al.
ONCOLOGY (2011)
Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea]
Eberval Gadelha Figueiredo et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2010)
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Thomas Reithmeier et al.
BMC CANCER (2010)
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
James R. Perry et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
Alessandra Fabi et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme Clinical article
Tomokazu Aoki et al.
JOURNAL OF NEUROSURGERY (2010)
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
Doo-Sik Kong et al.
NEURO-ONCOLOGY (2010)
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
Emilie Allard et al.
BIOMATERIALS (2009)
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
Alessandra Fabi et al.
BMC CANCER (2009)
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Alba A. Brandes et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
Jennifer A. Quinn et al.
CLINICAL CANCER RESEARCH (2009)
A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
Maria Grazia Fabrini et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Management of newly diagnosed glioblastoma: guidelines development, value and application
Jeffrey J. Olson et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Rechallenge with temozolomide in patients with recurrent gliomas
Antje Wick et al.
JOURNAL OF NEUROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
M. Glas et al.
ONCOLOGY (2009)
Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience
Silvia Scoccianti et al.
ANTI-CANCER DRUGS (2008)
Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
Casilda Balmaceda et al.
CANCER (2008)
Temozolomide Rechallenge in Recurrent Malignant Glioma by Using a Continuous Temozolomide Schedule The Rescue Approach
James R. Perry et al.
CANCER (2008)
Guidelines for the treatment of newly diagnosed glioblastoma: introduction
Jeffrey J. Olson et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients
Antonio Silvani et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
Antje Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?
Manuela Caroli et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme
Michael A. Badruddoja et al.
NEURO-ONCOLOGY (2007)
Pegylated liposomal doxorubicin in recurrent malignant glioma: Analysis of a case series
Martin Glas et al.
ONCOLOGY (2007)
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma:: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
A. A. Brandes et al.
BRITISH JOURNAL OF CANCER (2006)
Cystemustine in recurrent high grade glioma
X. Durando et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Temozolomide for recurrent or progressive high-grade malignant glioma: Results of an Austrian multicenter observational study
Marco Hassler et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
MD Prados et al.
NEURO-ONCOLOGY (2006)
PCV chemotherapy for recurrent glioblastoma
F Schmidt et al.
NEUROLOGY (2006)
Salvage temozolomide for prior temozolomide responders
E Franceschi et al.
CANCER (2005)
Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma
A Boiardi et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study
HS Gwak et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma
DA Reardon et al.
CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma
U Herrlinger et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: Final report of RTOG 9404
MD Prados et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme
MC Chamberlain et al.
CANCER (2004)
Temozolomide in the treatment of recurrent malignant glioma
SM Chang et al.
CANCER (2004)
Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma
ML Gruber et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium
E Everaert et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
EM Kemper et al.
CANCER TREATMENT REVIEWS (2004)
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy:: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
AA Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients
A Silvani et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
One week on/one week off:: A novel active regimen of temozolomide for recurrent glioblastoma
W Wick et al.
NEUROLOGY (2004)
Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme
SL Chua et al.
NEURO-ONCOLOGY (2004)
How effective is BCNU in recurrent glioblastoma in the modern era?: A phase II trial
AA Brandes et al.
NEUROLOGY (2004)
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
MJ van den Bent et al.
ANNALS OF ONCOLOGY (2003)
A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme
AA Brandes et al.
NEUROLOGY (2002)
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
C Twelves et al.
ANNALS OF ONCOLOGY (2002)
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada et al.
ANNALS OF ONCOLOGY (2001)
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma:: A phase II study
AA Brandes et al.
ANNALS OF ONCOLOGY (2001)
PCV chemotherapy for recurrent glioblastoma multiforme
AC Kappelle et al.
NEUROLOGY (2001)
Second line chemotherapy with docetaxel in patients with recurrent malignant glioma:: a phase II study
M Sanson et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme
MA Rosenthal et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Treosulfan chemotherapy for recurrent malignant glioma
F Schmidt et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
